Absolutely, Azure has no control over the timing of the release of Alacran results
But as you say, they’re ‘expected’ imminently. In my opinion these results are the most likely source of a positive rerate in the near term (both in terms of exploration findings and expenditure on Y2 work program, should this be announced)
Other people may be more focused on Oposura or San Alicia (although all evidence to date suggests these tenements have not fired up the imagination of the market at large). That’s fine. There’s no rule saying we must all concur on value drivers.